ARCS Australia
Cognitio
Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting
Be sure to visit the podcast's website and support the creator: www.arcs.com.au
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Why do smart professionals still freeze in high-pressure moments? 09.03.2026 29:40
In this episode of Cognitio , ARCS CEO Tim Boyle explores the behavioural science behind leadership, compliance and decision-making in regulated environments. Despite extensive training and detailed SOPs, deviations still occur. So what’s missing? This conversation dives into the psychology of identity-based leadership, the forgetting curve, grey zone decision-making, and how culture shapes compli...
ARCS Weekly Wrap 6 March 2026 06.03.2026 2:38
What are the three biggest developments shaping Australia’s life sciences sector this week? In this short weekly briefing, ARCS CEO Tim Boyle shares the top stories from across the medicines, medical devices and clinical research ecosystem. This week’s episode covers: • A major step toward professional standards and competency-based accreditation for the clinical trials workforce following discuss...
From Trial to Market: Navigating Pharmacovigilance Case Management Differences 02.03.2026 11:55
What changes when a therapy moves from clinical trials to the real world? In this episode of the Cognitio podcast, ARCS Australia CEO Tim Boyle speaks with Carl Bufe about the critical differences between clinical development safety management and post-market pharmacovigilance. From SUSAR reporting and ICH E6 to ICH E2D, signal detection, spontaneous adverse event reporting and scaling safety syst...
ARCS Weekly Wrap 27 February 2026 26.02.2026 2:49
This week in Australian life sciences: a $1.6B digital health acquisition, global momentum in cell and gene therapy, AI in regulatory affairs, and registrations opening for the 2026 ARCS Annual Conference. In this short episode, Tim Boyle breaks down the top 3 stories shaping biotech, medtech, clinical trials and therapeutic product commercialisation across Australia and the Asia-Pacific. Fast ins...
Cell & Gene Therapy in Australia: Are We Ready? 23.02.2026 11:20
Cell and gene therapies are transforming medicine — from CAR-T in oncology to next-generation gene therapies targeting rare disease. Ahead of the ARCS–DIA Cell & Gene Therapy Summit, Tim Boyle and Anna Megalakakis unpack Australia’s advanced therapies landscape. They explore manufacturing capability, workforce shortages, funding reform, regulatory pathways, and whether Australia can scale beyo...
ARCS Weekly Wrap 20 February 2026 19.02.2026 4:27
This week’s ARCS sector update covers three major developments shaping Australia’s medtech and pharmaceutical landscape. We unpack the AMR 2026 Summit in Sydney and the release of the Sixth AURA Report, highlighting why antimicrobial resistance is now an economic and national resilience issue. We examine the surge in PBS activity, with more than 20 medicines nearing listing decisions, and what thi...
South Korea: An Emerging Powerhouse in Clinical Trials and Pharmacovigilance 18.02.2026 23:58
South Korea has rapidly established itself as one of the world’s leading destinations for clinical research. With dense urban populations, advanced hospital infrastructure and a highly structured regulatory framework, it is now consistently ranked among the top countries globally for clinical trial activity. In this episode of the Cognitio Podcast, we explore what makes South Korea such a compelli...
ARCS Weekly Wrap 13 February 2026 13.02.2026 2:45
Global recognition for the TGA. PBS tensions escalating into legal action. And major leadership shifts across pharma. In this episode, Tim Boyle breaks down the three biggest stories shaping Australia’s life sciences sector this week — and why they matter for regulatory affairs, market access, clinical research and pharma professionals. What does WHO recognition mean for the TGA’s global influence...
Advancing LGBTQIA+ Inclusion in Healthcare 10.02.2026 40:12
Advancing LGBTQIA+ Inclusion in Healthcare and Research In this episode of Cognitio , ARCS Australia CEO Tim Boyle explores why LGBTQIA+ inclusion is no longer optional in healthcare, clinical research, and the life sciences sector. Drawing on insights from an ARCS webinar featuring guests from Proud Science Alliance and ACON, this episode unpacks the real-world consequences of under-representatio...
ARCS Weekly Wrap 6 February 2026 06.02.2026 2:55
A big week for policy, funding and medicine access. In this episiode, I break down my top three life sciences stories for the week and why they matter for Australia’s sector. ARCS members get the full weekly briefing via email. Join ARCS to stay across what matters.
ARCS Weekly Wrap 5th December 2025 05.12.2025 8:14
🎙️ ARCS Weekly News Wrap — Final Episode of 2025 Tim and Anna team up for the final Weekly News Wrap of the year, bringing you the most significant stories shaping Australia’s life sciences landscape. This fast, engaging episode covers the biggest pharma leadership moves, biotech breakthroughs, rare disease reform, PBS milestones, digital health shake-ups, and major medtech developments — includin...
Yarning Up Research: shifting from “done to” to “done with” in Aboriginal health trials 01.12.2025 32:38
Inclusive clinical research is not a box to tick. It is a way of working. In this episode of the Cognitio Podcast, Tim Boyle is joined by webinar presenters Jane Gaunson, Olivia Payne, Mariam Hachem and Bernard Kelly-Edwards to explore practical strategies for partnering with Aboriginal and Torres Strait Islander communities in clinical research. The conversation highlights the role of the Victori...
ARCS Weekly Wrap 28 November 2025 27.11.2025 11:44
In this week’s ARCS Weekly News Wrap, Tim Boyle unpacks the headlines shaping Australia’s medicines, medtech and biotech sectors, with a sharp eye on what they mean for professionals working across the product lifecycle. We cover key policy and reimbursement signals, regulatory and manufacturing developments, notable biotech and medtech milestones, and the people moves that hint at where the marke...
Heart of Australia 24.11.2025 43:18
In this episode of the Cognitio Podcast, Tim Boyle introduces a powerful conversation on innovation, access, and equity in clinical trials. Featuring Julia Linda from Eli Lilly Australia and Melissa Reilly from Heart of Australia , the episode explores how clinical research can be delivered to regional, rural, and First Nations communities through innovative models and strong cross-sector partners...
ARCS Weekly Wrap 21 November 2025 21.11.2025 8:27
In this week’s ARCS Weekly News Wrap, Tim Boyle recaps a major week for Australia’s life sciences sector during National Clinical Trials Week. The episode covers key developments across pharma, medtech, biotech, policy and investment, along with insights from ARCS’ activities in Melbourne, including the launch of the Clinical Workforce White Paper, the new ARCS and MAPA strategic alliance, and sec...
Pharmacovigilance and Equity: Medicine Safety for First Nations Communities 17.11.2025 30:41
In this episode of the Cognitio Podcast, host Tim Boyle explores one of the most critical equity challenges in Australian healthcare: ensuring safe, effective, culturally informed use of medicines for First Nations peoples. Tim is joined by four respected leaders in medicine safety: Karen Battat (AstraZeneca), Vinham Mehta (Novartis), Marcela Bade (former TGA pharmacovigilance inspector) and Matt...
ARCS Weekly Wrap 14 November 2025 14.11.2025 9:45
This week’s wrap brings you the biggest developments across Australia’s life sciences sector — all in one quick, engaging update. We cover major pharma moves, medtech breakthroughs, biotech investment momentum, regulatory updates, and the latest people movements shaping the industry. From gene therapy and GLP-1 dealmaking to AI in radiology and standout Australian clinical results, this episode hi...
What is Intellectual Property? 10.11.2025 50:07
What is Intellectual Property? A Practical Guide for Australia’s Life Sciences Sector In this episode of Cognitio , Tim Boyle takes listeners on a clear and engaging tour of the intellectual property landscape, guided by three specialists from Spruson and Ferguson Lawyers. IP sits at the core of innovation and commercialisation in the life sciences, yet it is often misunderstood or overlooked unti...
ARCS Weekly Wrap 7th November 2025 06.11.2025 8:51
In this week’s episode, Anna Megalakakis steps behind the mic to bring you a fast-paced and insightful roundup of the biggest developments across Australia’s life sciences sector. From blockbuster pharma shifts and cutting-edge medtech launches to biotech investment momentum and major leadership movements, this episode unpacks what matters — and why. Anna also shares the latest from ARCS, includin...
AI in Regulatory Affairs: From Burden to Breakthrough 03.11.2025 29:12
In this episode of The Cognitio Podcast , ARCS Australia CEO Tim Boyle introduces highlights from a thought-provoking ARCS Interest Area webinar, Automating Life Science Workflows through AI , presented by Dr Rishi Verma , CEO and Founder of Stethy AI . Dr Verma, a physician and engineer, takes listeners inside the fast-evolving world of artificial intelligence in the life sciences. Drawing direct...
ARCS Weekly Wrap 31st October 2025 31.10.2025 8:02
This week’s episode dives into the biggest stories shaping Australia’s life sciences landscape — from global leadership milestones to biotech breakthroughs and policy reform. We celebrate Professor Tony Lawler’s appointment as Global Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) , marking Australia’s growing influence in global regulatory science. In pharma, Take...
Next Generation Nuclear Medicine 27.10.2025 43:57
Next Generation Nuclear Medicine: Powering the Future of Precision Health In this episode of ARCS Cognitio , ARCS Australia CEO Tim Boyle leads a compelling conversation on the rapidly evolving world of next-generation nuclear medicines — where physics meets biology to transform how we diagnose and treat disease. Joined by a panel of industry leaders — Christian Behrenbruch (Telix Pharmaceuticals)...
ARCS Weekly Wrap 24th October 2025 24.10.2025 8:13
ARCS Weekly News Wrap – Week Ending 25 October 2025 This week’s episode covers a powerhouse mix of policy shifts, scientific breakthroughs, and leadership changes shaping Australia’s life sciences landscape. Join Tim Boyle , CEO of ARCS Australia, as he unpacks: Pharma: Landmark PBS listings, proactive pharmacovigilance, and new rare disease breakthroughs Medtech: HTA review tensions, hospital fun...
ARCS Weekly Wrap 17 October 2025 17.10.2025 6:46
In this week’s ARCS Weekly News Wrap, Tim Boyle returns from Adelaide after the KCA Conference to bring you the top stories shaping Australia’s life sciences sector. This episode covers: • Pharma: FDA approval for MSD’s subcutaneous Keytruda, Eli Lilly’s oral obesity drug heading to the TGA, and J&J’s Stelara patent challenge. • Medtech: AI-assisted diagnostics at Macquarie University and Opta...
ARCS Weekly Wrap 26 September 2025 26.09.2025 6:36
This week’s ARCS Weekly News Wrap dives into the biggest stories shaping pharma, medtech, biotech, and the workforce behind them. From the MAPA-MAPS Summit and student careers fairs to global debates over paracetamol, robotic surgery innovations, and major biotech funding deals — we break it all down and explain what it means for you. Highlights include: The rise of medical affairs and ARCS’ caree...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.